Methotrexate plus sulfasalazine is recommended in patients with all disease durations provided they have high disease activity and poor prognostic features.
甲氨喋呤加柳氮磺吡啶疗法是推荐给那些患病时间长久,病情高度活动、但是没有不良预后特征的患者。
Hydroxychloroquine plus sulfasalazine is recommended only for patients with intermediate disease duration (6-24 months) and high disease activity but without poor prognostic features.
羟氯喹加柳氮磺吡啶疗法是只推荐给那些患病时间中等(6 - 24个月),病情重但是没有不良预后特征的患者。
应用推荐